Heat-inactivated modified vaccinia virus Ankara (MVA) as vaccine adjuvant

被引：0
|
作者：
Yang, Ning [1 ]
Shuman, Stewart [1 ]
Merghoub, Taha [1 ]
Wolchok, Jedd [1 ]
Deng, Liang [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P116
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Modified vaccinia virus Ankara as a vaccine against feline coronavirus: immunogenicity and efficacy
    Hebben, M
    Duquesne, W
    Cronier, J
    Rossi, B
    Aubert, A
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2004, 6 (02) : 111 - 118
  • [32] A Novel Monoclonal Antibody Against a Modified Vaccinia Ankara (MVA) Envelope Protein as a Tool for MVA Virus Titration by Flow Cytometry
    Cua, Simeon
    Tello, Brenda A.
    Farelo, Mafalda A.
    Rodriguez, Esther
    Escalante, Gabriela M.
    Mutsvunguma, Lorraine Z.
    Ogembo, Javier Gordon
    Reidel, Ivana G.
    VIRUSES-BASEL, 2024, 16 (10):
  • [33] Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia
    Wang, Weiyi
    Liu, Shuaitong
    Dai, Peihong
    Yang, Ning
    Wang, Yi
    Giese, Rachel A.
    Merghoub, Taha
    Wolchok, Jedd
    Deng, Liang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (09)
  • [34] Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors
    Goossens, Martine
    Pauwels, Katia
    Willemarck, Nicolas
    Breyer, Didier
    CURRENT GENE THERAPY, 2013, 13 (06) : 413 - 420
  • [35] Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE® against aerosolized rabbitpox virus in a rabbit model
    Garza, Nicole L.
    Hatkin, Josh M.
    Livingston, Virginia
    Nichols, Donald K.
    Chaplin, Paul J.
    Volkmann, Ariane
    Fisher, Diana
    Nalca, Aysegul
    VACCINE, 2009, 27 (40) : 5496 - 5504
  • [36] Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination
    Verheust, Celine
    Goossens, Martine
    Pauwels, Katia
    Breyer, Didier
    VACCINE, 2012, 30 (16) : 2623 - 2632
  • [37] Expression of an Efficient Selection Marker Out of a Duplicated Site in the ITRs of a Modified Vaccinia Virus Ankara (MVA)
    Abidi, Sirine
    Fernandez, Aurora Elhazaz
    Seehase, Nicole
    Hanisch, Lina
    Karlas, Alexander
    Sandig, Volker
    Jordan, Ingo
    VACCINES, 2024, 12 (12)
  • [38] Diversity of cell death signaling pathways in macrophages upon infection with modified vaccinia virus Ankara (MVA)
    Klaas, Lioba
    Vier, Juliane
    Gentle, Ian E.
    Hacker, Georg
    Kirschnek, Susanne
    CELL DEATH & DISEASE, 2021, 12 (11)
  • [39] Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: A murine tumor model
    Carroll, MW
    Overwijk, WW
    Chamberlain, RS
    Rosenberg, SA
    Moss, B
    Restifo, NP
    VACCINE, 1997, 15 (04) : 387 - 394
  • [40] Introduction of the Six Major Genomic Deletions of Modified Vaccinia Virus Ankara (MVA) into the Parental Vaccinia Virus Is Not Sufficient To Reproduce an MVA-Like Phenotype in Cell Culture and in Mice
    Meisinger-Henschel, Christine
    Spaeth, Michaela
    Lukassen, Susanne
    Wolferstaetter, Michael
    Kachelriess, Heike
    Baur, Karen
    Dirmeier, Ulrike
    Wagner, Markus
    Chaplin, Paul
    Suter, Mark
    Hausmann, Juergen
    JOURNAL OF VIROLOGY, 2010, 84 (19) : 9907 - 9919
12345